Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-035913
Filing Date
2025-03-10
Accepted
2025-03-10 07:30:27
Documents
17
Effectiveness Date
2025-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 dsgn-20250310.htm S-8 101547
2 EX-5.1 dsgn-ex5_1.htm EX-5.1 22210
3 EX-23.1 dsgn-ex23_1.htm EX-23.1 4531
4 EX-FILING FEES dsgn_exfilingfees.htm   iXBRL EX-FILING FEES 51138
5 GRAPHIC img205676976_0.jpg GRAPHIC 5962
6 GRAPHIC img205676976_1.jpg GRAPHIC 5962
  Complete submission text file 0000950170-25-035913.txt   359624

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT dsgn_exfilingfees_htm.xml XML 19602
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285660 | Film No.: 25722149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)